Matches in SemOpenAlex for { <https://semopenalex.org/work/W2361496678> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2361496678 abstract "Objective To investigate the synergistic effects of rosiglitazone(ROZ)and cisplatin on the growth of the human endometrial cancer cell line KLE xenografted to nude mice.Methods KLE cells were transplanted into nude mice to form the study model.When the models were established,they were randomly divided into 6 groups:the control group(A),the cisplatin1 mg/kg group(B),the cisplatin 3 mg/kg group(C),the ROZ 50 mg/kg group(D),the cisplatin1 mg/kg+ROZ 50 mg/kg group(E),and cisplatin 3 mg/kg+ROZ 50 mg/kg group(F).Cisplatin was given by intraperitoneal injection every two days and ROZ was intragastrically administered every day.During the period of observation,the volumes of the transplanted tumors were measured every 4 days.The tumor growth inhibitory rates of each group were calculated.Also,the curves of BALB/c-nude mice growth were drawn.After 38 days,BALB/c-nude mice were euthanized and xenograft tumors were measured.Expression of NF-κB and PTEN protein in subcutaneous tumors were determined by immunohistochemical method with an image analysis system.Results Significant differences in tumor inhibitory rates were found between the treatment groups and the control group(P0.05).The tumor inhibitory rate of B,C,D,E,F 5 group was 24.41%,43.34%,49.67%,78.02%,84.78%,respectively,and the combination group showed synergistic effect on inhibiting the growth of the xenografts.Contrary to the control group,expression of subcutaneous tumor NF-κB was down-regulated and PTEN was obviously up-regulated by rosiglitazone and its combination with cisplatin.Conclusion Rosiglitazone could enhance inhibition of the growth of endometrial tumor in combination with cisplatin." @default.
- W2361496678 created "2016-06-24" @default.
- W2361496678 creator A5020787482 @default.
- W2361496678 date "2010-01-01" @default.
- W2361496678 modified "2023-09-27" @default.
- W2361496678 title "Inhibitory effect of rosiglitazone combined with cisplatin on the growth of endometrial carcinoma in Nude Mice" @default.
- W2361496678 hasPublicationYear "2010" @default.
- W2361496678 type Work @default.
- W2361496678 sameAs 2361496678 @default.
- W2361496678 citedByCount "0" @default.
- W2361496678 crossrefType "journal-article" @default.
- W2361496678 hasAuthorship W2361496678A5020787482 @default.
- W2361496678 hasConcept C121608353 @default.
- W2361496678 hasConcept C126322002 @default.
- W2361496678 hasConcept C134018914 @default.
- W2361496678 hasConcept C17077164 @default.
- W2361496678 hasConcept C185592680 @default.
- W2361496678 hasConcept C190283241 @default.
- W2361496678 hasConcept C204232928 @default.
- W2361496678 hasConcept C2776390293 @default.
- W2361496678 hasConcept C2776694085 @default.
- W2361496678 hasConcept C2777609662 @default.
- W2361496678 hasConcept C2778239845 @default.
- W2361496678 hasConcept C2780159080 @default.
- W2361496678 hasConcept C2780278673 @default.
- W2361496678 hasConcept C2780678043 @default.
- W2361496678 hasConcept C55493867 @default.
- W2361496678 hasConcept C71924100 @default.
- W2361496678 hasConcept C86554907 @default.
- W2361496678 hasConcept C98274493 @default.
- W2361496678 hasConceptScore W2361496678C121608353 @default.
- W2361496678 hasConceptScore W2361496678C126322002 @default.
- W2361496678 hasConceptScore W2361496678C134018914 @default.
- W2361496678 hasConceptScore W2361496678C17077164 @default.
- W2361496678 hasConceptScore W2361496678C185592680 @default.
- W2361496678 hasConceptScore W2361496678C190283241 @default.
- W2361496678 hasConceptScore W2361496678C204232928 @default.
- W2361496678 hasConceptScore W2361496678C2776390293 @default.
- W2361496678 hasConceptScore W2361496678C2776694085 @default.
- W2361496678 hasConceptScore W2361496678C2777609662 @default.
- W2361496678 hasConceptScore W2361496678C2778239845 @default.
- W2361496678 hasConceptScore W2361496678C2780159080 @default.
- W2361496678 hasConceptScore W2361496678C2780278673 @default.
- W2361496678 hasConceptScore W2361496678C2780678043 @default.
- W2361496678 hasConceptScore W2361496678C55493867 @default.
- W2361496678 hasConceptScore W2361496678C71924100 @default.
- W2361496678 hasConceptScore W2361496678C86554907 @default.
- W2361496678 hasConceptScore W2361496678C98274493 @default.
- W2361496678 hasLocation W23614966781 @default.
- W2361496678 hasOpenAccess W2361496678 @default.
- W2361496678 hasPrimaryLocation W23614966781 @default.
- W2361496678 hasRelatedWork W1979663197 @default.
- W2361496678 hasRelatedWork W2008187359 @default.
- W2361496678 hasRelatedWork W2348071174 @default.
- W2361496678 hasRelatedWork W2350656554 @default.
- W2361496678 hasRelatedWork W2355483912 @default.
- W2361496678 hasRelatedWork W2357355043 @default.
- W2361496678 hasRelatedWork W2362923964 @default.
- W2361496678 hasRelatedWork W2363003443 @default.
- W2361496678 hasRelatedWork W2366271449 @default.
- W2361496678 hasRelatedWork W2369071974 @default.
- W2361496678 hasRelatedWork W2372472785 @default.
- W2361496678 hasRelatedWork W2373660558 @default.
- W2361496678 hasRelatedWork W2376976586 @default.
- W2361496678 hasRelatedWork W2381325625 @default.
- W2361496678 hasRelatedWork W2384120296 @default.
- W2361496678 hasRelatedWork W2385410762 @default.
- W2361496678 hasRelatedWork W2390044649 @default.
- W2361496678 hasRelatedWork W2393235583 @default.
- W2361496678 hasRelatedWork W2491501156 @default.
- W2361496678 hasRelatedWork W3030508989 @default.
- W2361496678 isParatext "false" @default.
- W2361496678 isRetracted "false" @default.
- W2361496678 magId "2361496678" @default.
- W2361496678 workType "article" @default.